PrintFriendly

Print Friendly, PDF & Email

340B Program Module Available through Partners in Bleeding Disorders Education

March 17, 2017
340B Program Module Available through Partners in Bleeding Disorders Education

The Partners in Bleeding Disorders Education Program is offering an educational module for healthcare providers at US hemophilia treatment centers (HTCs) who want to learn more about the 340B Drug Pricing Program. The target audience for this activity includes nurses, pharmacists, pharmacy technicians and additional staff who want to learn more about the program’s relevance to HTCs.

Born out of the Veteran’s Health Care Act of 1992, the 340B Program allows certain hospitals and other eligible healthcare providers such as federally-recognized HTCs to obtain discounted prices on prescription drugs and biologics (other than vaccines) from drug manufacturers. These manufacturers are required to offer 340B discounts to covered entities to have their drugs covered under Medicaid. The program, which is managed by the Health Resources and Services Administration (HRSA), allows participating HTCs to “stretch” their federal dollars on the condition that all revenues yielded from the program are invested back into patient services, care coordination, research and other programs that demonstrate a direct benefit to patients.

The module is designed to meet the following educational objectives:

  • Explain homecare provision and the role of the 340B Pharmacy Program
  • Describe Section 340B of the Veterans Health Care Act
  • Define 340B Pharmacy Program eligibility and enrollment
  • Identify restrictions, requirements and special considerations to operate a 340B Pharmacy Program

“The 340B Pharmacy Program and the HTC” activity is provided for 0.5 contact hours under American Nurses Credentialing Center (ANCC) criteria. The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the ANCC’s Commission on Accreditation.

Established in 1996, the Partners Program promotes excellence in care through education created by and for the federally recognized HTC network and providers from a variety of disciplines that serve patients with bleeding and other coagulation disorders. The program is a collaborative initiative of the Indiana Hemophilia & Thrombosis Center, NHF and the Hemophilia Foundation of Michigan. Funding to support the Partners in Bleeding Disorders Education Program is provided through an unrestricted educational grant from Shire.

Learn more about “The 340B Pharmacy Program and the HTC Details,” and other online educational activities by going to the PartnersPRN web site.